Clinical Trial Update: NAC for Treatment-Resistant OCD and Other Related Disorders [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update for N-acetylcysteine in treatment-resistant obsessive-compulsive disorder; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Guangdong Provincial People's Hospital | Conditions: Obsessive Compulsive Disorder (OCD) | Phase 4 | Status: ACTIVE_NOT_RECRUITING